Наконец-то свершилось, появились первые результаты робот-вспомогательных интервенций [Ссылки могут видеть только зарегистрированные и активированные пользователи]
Сайт производителя, правда с весьма скудной информацией : [Ссылки могут видеть только зарегистрированные и активированные пользователи]
"The aim is to be more precise and to provide more control of the procedure," said Granada. "Control includes not only control of the device but also of the environment. You're comfortably sitting down, you can control everything manually. It pretty much provides an automatization of the procedure."
"You can imagine procedures where you need two wires, ballooning one branch and then the other, and where you have to do a lot of sequential stuff," he said. "You're sitting down, looking at the screen and controlling every single device, so it gives you more comfort and precision and hopefully better patient outcomes."
_______________________________________________
Вот так значит, сидишь перед монитором с джойстиком в руках и оказываешся не геймером, а крутым хирургом. КРАСИВО, черт побери.
Next up for the CorPath 200 system is a prospective, multicenter, nonrandomized US study that will test the safety and efficacy of the technology in a larger group of patients. That study, known as Percutaneous Robotically Enhanced Coronary Intervention Study (PRECISE), is led by Weisz and Dr Joseph Carrozza (St Elizabeth's Medical Center, Boston, MA) and is expected next year. Currently, a price tag on the investigational remote-control system has not been set.
Интересно, а как выглядело бы рандомизированное исследование:)